GlassScriptPhysician profile
Antonio Ferrey
NPI 1750417549
$4,326.24
in general payments reported to CMS, 2019-2025
34 companies · $863 in 2025
The $863 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,076 · 2020: $139 · 2021: $440 · 2022: $456 · 2023: $606 · 2024: $746 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,215.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $522.84 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $517.18 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $386.74 | 2019-2025 | Spravato |
| Astrazeneca Pharmaceuticals LP | $337.15 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $313.52 | 2019-2025 | Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.34 | 2019-2025 | Jardiance, Tradjenta |
| Novartis Pharmaceuticals Corporation | $196.77 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $177.88 | 2019-2024 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $168.79 | 2019-2025 | |
| Pfizer INC. | $161.20 | 2019-2024 | |
| Amgen INC. | $147.35 | 2019-2025 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $143.51 | 2021-2025 | |
| Abiomed | $143.07 | 2023-2024 | Impella |
| Abbott Laboratories | $125.26 | 2022-2025 | Freestyle Libre 3 |
| Abbvie INC. | $95.69 | 2021-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $75.30 | 2019-2025 | |
| Amarin Pharma, INC. | $67.89 | 2019-2020 | |
| Dexcom, INC. | $60.93 | 2021-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $45.74 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $44.62 | 2019 | |
| Phathom Pharmaceuticals, INC. | $35.05 | 2024 | Voquezna |
| Astellas Pharma US INC | $33.72 | 2021 | |
| Daiichi Sankyo INC. | $33.17 | 2019-2021 | |
| Exact Sciences Corporation | $31.75 | 2025 | Cologuard Collection Kit |
| Teleflex LLC | $27.80 | 2025 | Urolift |
| Exeltis, USA INC. | $24.34 | 2023 | Slynd |
| Sun Pharmaceutical Industries INC. | $22.23 | 2022 | |
| Mayne Pharma Commercial LLC | $21.95 | 2023 | |
| Edwards Lifesciences Corporation | $17.46 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Grifols USA, LLC | $16.30 | 2019 | |
| Kyowa Kirin, INC. | $16.17 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $15.63 | 2019 | |
| Boston Scientific Corporation | $15.52 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Ferrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.